A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
Clinical trial NCT04380103 · UNKNOWN
Trial details
- NCT number
- NCT04380103
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-26
- Primary completion
- 2020-12-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.